Indian Pharmaceuticals & Biotech Undervalued Small Caps

Granules India

Market Cap: ₹107.0b

Manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationlly.

Marksans Pharma

Market Cap: ₹102.6b

Engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally.